The decline of hepatitis B viral infection in South-Western Saudi Arabia

Saudi Medical Journal

Volumn 24, Issue 9, 2003, Pages 991-995

  Ayoola, Ayobanji E ^a,c   Tobaigy, Mohsen S ^b   Gadour, Mohammed O ^a   Ahmad, Basher S ^b   Hamza, Margani K ^a   Ageel, Abdurahim M ^c  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b King Fahad Central Hospital   (Saudi Arabia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HEALTH EDUCATION; HEALTH SURVEY; HEPATITIS B; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SAUDI ARABIA; SCHOOL CHILD; SOCIOECONOMICS; VACCINATION; VIRUS TRANSMISSION; VOLUNTEER;

ADOLESCENT; ADULT; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOBLOTTING; INFANT; MALE; PREVALENCE; SAUDI ARABIA;

EID: 0141892052     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Faleh FZ, Ayoola EA, Arif M, Ramia S, Rashed R, Al-Jeffry M et al. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J Infect 1992; 24; 197-206.
2. Faleh FZ. Hepatitis B infection in Saudi Arabia. Annals of Saudi Medicine 1988; 8: 474-480.
3. Shobokshi OA, Serebour FE, Skakni L. Hepatitis B surface gene mutants and their emerging role in the efficacy of HBV vaccination programme. Annals of Saudi Medicine 1999; 19: 87-92.
4. Arya SC, Ashraf SJ, Parande CM, El-Sayed M, Sahay R, Ageel AR et al. Hepatitis B virus in Jizan, Saudi Arabia. J Med Virol 1985; 17: 267-274.
5. El-Hazmi MAC. Hepatitis B markers in Saudi Arabia: A comparative study in different regions. Annals of Saudi Medicine 1986; 6: 185-190.
6. Ikram MH, Ali SI, Khawaja FI, Awad AH. Hepatitis B virus marker among the blood donors in Medina Munawara. Annals of Saudi Medicine 1988; 8: 470-473.
7. El-Hazmi MA. Hepatitis B in Saudi Arabia. J Trop Med Hyg 1989; 92: 56-61.
8. Ashraf SJ, Arya SC, El-Sayed M, Sahay R, Parande CM, Tajuddin MR et al. A profile of primary hepatocellular carcinoma patients in the Jizan area of Saudi Arabia. Cancer 1986; 58: 2163-2168.
9. Tandon P, Pathak VP, Zaheer A, Chatterjee A, Wilford N. Cancer in the Jizan province of Saudi Arabia: An eleven year study. Annals of Saudi Medicine 1995; 15: 14-20.
10. Faleh FZ, Ayoola EA, Al-Jeffri M, Arif M, Al-Rashed RS, Ramia S. Integration of hepatitis B vaccine into the expanded program on immunization: The Saudi Arabian experience. Annals of Saudi Medicine 1993; 13: 231-236.
11. Ayoola EA, Want MA, Gadour MOEH, Al-Hazmi MH, Hamza MKM. Hepatitis E virus infection in hemodialysis patients: a case control study in Saudi Arabia. J Med Virol 2002; 66: 329-334.
12. Armiatge P, Berry G. Statistical methods in medical research, 3rd ed. Oxford (UK): Blackwell Scientific Publications; 1994. p. 1-42.
13. Fathala SE, Al-Jama AA, Al-Sheikh IH, Islam SI. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J 2000; 21: 945-949
14. Sobeslavsky O. Prevalence of markers of HBV infection in various countries: A WHO collaborative study. Bull World Health Organ 1980; 58: 621-628.
15. Papaevangelou G. Perspectives on viral hepatitis elimination in Europe. In: Nishioka K, Suzuki H, Minshiro S, Ode T, editors. Viral Hepatitis and Liver Disease: Tokyo (JN): Springer-Verlag; 1994. p. 435-438.
16. Hoofnagle JH, Gerety RJ, Barker LF. Antibody to hepatitis B core antigen. In: Greenwalt TJ, Jamieson GA, editors: Transmissible Disease and Blood Transfusion. New York (NY): Grune and Stratton; 1974. p. 43-55.
17. Szmuness W, Hoofnagle JH, Stevens CE, Prince AM. Antibody against the hepatitis type B core antigen: a tool for epidemiologic studies. Am J Epidemiol 1976; 104: 256-262.
18. Fathalla SE, Namnyak SS, Al-Jama AA, Bautista MM. The prevalence of hepatitis B surface antigen in healthy subjects residing in the Eastern Province of Saudi Arabia. Saudi Med J 1985; 6: 236-241.
19. Tandon BV, Tandon A. Epidemiological trends of viral hepatitis in Asia: In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral Hepatitis and Liver Disease. Turin (Italy): Edizioni Minerva Medica; 1997. p. 559-561.
20. Alter MJ, Shapiro CN, Coleman PJ, Margolis HS. Viral hepatitis in North America. In: Nishioka K, Suzuki H, Mishiro S, Oda T. editors. Viral Hepatitis and Liver Disease. Tokyo (JN): Springer-Verlag; 1994. p. 435-438.
21. Ayoola EA. Viral hepatitis in Africa. In: Zuckerman AJ, editor. Viral Hepatitis and Liver Diseases. New York (NY): Liss; 1988. p. 161-169.
22. Faleh FZ , Al-Jeffri M, Ramia S, Al-Rashed R, Arif M, Rezeig M et al. Seroepidemiology of hepatitis B virus infection in Saudi children after a mass hepatitis B vaccination programme. J Infect 1999; 38: 167-170.
23. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ et al. Efficacy of hepatitis B vaccine in the Gambian expanded programme of immunisation. Lancet 1995; 341: 1129-1131.
24. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B virus infection in children in Tapei, 1989: five years after a mass hepatitis B vaccination programme. J Med Virol 1991; 34: 96-99.